Literature DB >> 10763818

p16 INK4a can initiate an autonomous senescence program.

C Y Dai1, G H Enders.   

Abstract

The tumor suppressor p16INK4a is a potent mediator of cell cycle arrest in transient expression studies, is induced in senescing cells, and can impose morphological features of senescence. Nonetheless, it is unclear whether p16INK4a can block cell proliferation irreversibly. We explored this issue using osteogenic sarcoma cell clones with inducible p16INK4a expression. Induction of p16INK4a for 1 day arrested most cells in G1 phase. If the induction was then interrupted, p16INK4a levels returned to baseline and robust growth resumed within 3-5 days. When p16INK4a was induced for 6 days DNA synthesis remained strongly inhibited and the cells acquired morphological features of senescence. Moreover, if p16INK4a induction was interrupted at this point and the cells were followed for 12 more days, most cells retained these morphologic features and either failed to divide or died. This occurred despite the prompt return of p16INK4a expression and retinoblastoma protein phosphorylation toward baseline levels. In fact, some senescing cells appeared to enter S phase. These results demonstrate that a sustained period of p16INK4a expression is sufficient in this setting to impose a durable block to cell proliferation and that this state becomes independent of p16INK4a expression, hypophosphorylation of pRB, or a strict G1 arrest.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10763818     DOI: 10.1038/sj.onc.1203438

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  55 in total

1.  A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.

Authors:  Avi Shvarts; Thijn R Brummelkamp; Ferenc Scheeren; Eugene Koh; George Q Daley; Hergen Spits; René Bernards
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

2.  Cellular senescence requires CDK5 repression of Rac1 activity.

Authors:  Kamilah Alexander; Hai-Su Yang; Philip W Hinds
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

3.  Co-regulation of p16INK4A and migratory genes in culture conditions that lead to premature senescence in human keratinocytes.

Authors:  Benjamin W Darbro; Galen B Schneider; Aloysius J Klingelhutz
Journal:  J Invest Dermatol       Date:  2005-09       Impact factor: 8.551

4.  p16(Ink4a) inhibits histologic progression and angiogenic signaling in min colon tumors.

Authors:  Steven L Gibson; Amelie Boquoi; Tina Chen; Norman E Sharpless; Colleen Brensinger; Greg H Enders
Journal:  Cancer Biol Ther       Date:  2005-12-09       Impact factor: 4.742

Review 5.  Radiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathway.

Authors:  Brian D Lehmann; James A McCubrey; David M Terrian
Journal:  Cancer Biol Ther       Date:  2007-08-05       Impact factor: 4.742

Review 6.  Telomere dynamics: the means to an end.

Authors:  M Matulić; M Sopta; I Rubelj
Journal:  Cell Prolif       Date:  2007-08       Impact factor: 6.831

7.  p63 deficiency activates a program of cellular senescence and leads to accelerated aging.

Authors:  William M Keyes; Ying Wu; Hannes Vogel; Xuecui Guo; Scott W Lowe; Alea A Mills
Journal:  Genes Dev       Date:  2005-08-17       Impact factor: 11.361

8.  Senescence delay and repression of p16INK4a by Lsh via recruitment of histone deacetylases in human diploid fibroblasts.

Authors:  Rui Zhou; Limin Han; Guodong Li; Tanjun Tong
Journal:  Nucleic Acids Res       Date:  2009-06-26       Impact factor: 16.971

9.  Decreasing expression of the G1-phase inhibitors, p21Cip1 and p16INK4a, promotes division of corneal endothelial cells from older donors.

Authors:  Nancy C Joyce; Deshea L Harris
Journal:  Mol Vis       Date:  2010-05-25       Impact factor: 2.367

10.  Feedback between p21 and reactive oxygen production is necessary for cell senescence.

Authors:  João F Passos; Glyn Nelson; Chunfang Wang; Torsten Richter; Cedric Simillion; Carole J Proctor; Satomi Miwa; Sharon Olijslagers; Jennifer Hallinan; Anil Wipat; Gabriele Saretzki; Karl Lenhard Rudolph; Tom B L Kirkwood; Thomas von Zglinicki
Journal:  Mol Syst Biol       Date:  2010-02-16       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.